Animal study shows human brain cells repair damage in multiple sclerosis

https://www.eurekalert.org/pub_releases/2020-05/uorm-ass051820.php

News Release 19-May-2020
University of Rochester Medical Center


A new study shows that when specific human brain cells are transplanted into animal models of multiple sclerosis and other white matter diseases, the cells repair damage and restore function. The study provides one of the final pieces of scientific evidence necessary to advance this treatment strategy to clinical trials.

•••••

This research is in the process of being developed by a University of Rochester start-up company Oscine Therapeutics. The company's experimental transplant therapy for multiple sclerosis and other glial diseases, such as Huntington's disease, is currently under early FDA review for clinical trials. Goldman is the scientific founder, an officer, and holds equity in the company.